U.K. Pharmaceuticals & Biotech Mid-Large Cap Stocks

Genus

Market Cap: UK£1.4b

Produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.

Hikma Pharmaceuticals

Market Cap: UK£3.2b

Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.

GSK

Market Cap: UK£75.0b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

AstraZeneca

Market Cap: UK£192.0b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Haleon

Market Cap: UK£32.7b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

HUTCHMED (China)

Market Cap: UK£1.5b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Oxford Nanopore Technologies

Market Cap: UK£1.1b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.